Isis Pharmaceuticals regulatory update

ISIP received U.S. Patent No. 5,563,255 covering Isis 5132/CGP69846A, an antisense inhibitor of C-raf kinase. The patent covers several antisense sequences targeted to C-raf kinase. The compound has i...